2026-11-092026-11-09https://scholars.csmu.edu.tw/handle/123456789/37405C型肝炎病毒干擾素瑞巴維林合併療法周邊血液單核細胞Hepatitis C virus (HCV)InterferonRibavirinCombination therapy Peripheral blood mononuclear cell多重因素影響干擾素-Ribavirin對慢性Ｃ型肝炎長期療效之評估Project